首頁 > 市場調查報告書 > 醫療設備

手術用器具黏結劑

纖維蛋白膠市場規模、佔有率和成長分析（按產品類型、技術、應用、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1900358

纖維蛋白膠市場規模、佔有率和成長分析（按產品類型、技術、應用、最終用戶和地區分類）—2026-2033年產業預測

Fibrin Sealants Market Size, Share, and Growth Analysis, By Product Type (Liquid, Patches), By Technology (Viral Inactivation, Autologous Donation), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 195 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球纖維蛋白膠市場規模將達到 6.3915 億美元，到 2025 年將達到 6.89 億美元，到 2033 年將達到 12.5652 億美元，預測期（2026-2033 年）的複合年成長率為 7.8%。

全球纖維蛋白膠市場的主要促進因素是外科手術數量的增加，而這又受到人口老化導致慢性疾病（例如心血管疾病和整形外科疾病）患者需要手術治療的影響。隨著複雜手術的增多，人們對纖維蛋白膠纖維蛋白膠高效能止血劑的依賴性也日益增強。這是因為纖維蛋白密封劑能夠快速形成穩定的血塊，增強組織密封性，最終減少出血量並縮短恢復時間。市場的主要趨勢包括生物技術和重組DNA技術的進步，這些技術促成了更安全、更有效的密封劑的研發，延長了其保存期限並降低了免疫抗原性風險。改良的生產流程使得合成的、無病原體的產品成為可能，而創新的配方技術則提高了黏合性和聚合速度。這些因素正在擴大纖維蛋白膠在外科手術中的臨床應用範圍和接受度。

推動全球纖維蛋白膠市場發展的因素

全球外科手術量的增加是推動全球纖維蛋白膠市場擴張的主要因素。心臟病、癌症和整形外科疾病等慢性病的日益增多，促使人們在手術過程中需要使用纖維蛋白膠有效的止血解決方案。隨著醫療機構尋求更先進的方案以改善患者預後並提高手術效率，對可靠且高效的手術器械日益成長的需求，在推動市場發展方面發揮關鍵作用。因此，對創新醫療解決方案的日益關注，進一步刺激了市場動態。

限制全球纖維蛋白膠市場的因素

全球纖維蛋白膠市場的成長受到監管挑戰和漫長核准流程的限制。在不同地區進行全面的臨床試驗並遵守監管標準，延長了產品研發週期，從而限制了新產品的上市。這種情況可能會阻礙尖端纖維蛋白膠解決方案的廣泛應用，最終影響該行業的市場動態和創新。儘管企業正在努力克服這些障礙，但及時獲得先進產品仍受到限制，這影響了尋求有效傷口管理方案的製造商和消費者。

全球纖維蛋白膠市場趨勢

受微創手術技術需求不斷成長的推動，全球纖維蛋白膠市場正經歷顯著成長。隨著醫療機構致力於改善患者預後，纖維蛋白膠因其有助於縮短恢復時間、減少出血量和提升整體手術效果而日益受到認可。其廣泛的應用，尤其是在心血管和整形外科手術領域，證實了其在精準度和快速恢復至關重要的手術中發揮的關鍵作用。這種不斷成長的需求不僅標誌著外科手術實踐的變革，也預示著一種趨勢，即採用能夠促進有效癒合和提升患者福祉的尖端材料。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Baxter International（USA）
CSL Limited（Australia）
Vivostat A/S（Denmark）
Grifols, SA（Spain）
Pfizer Inc.（USA）
Stryker Corporation（USA）
Hemarus（Australia）
Asahi Kasei Corporation（Japan）
Z-Medica（USA）
Marquee Biosurgical（USA）
Hualan Biological Engineering（China）
CryoLife, Inc.（USA）
Integra LifeSciences Corporation（USA）
Becton, Dickinson and Company（USA）
B. Braun SE（Germany）
Corza Medical（USA/Switzerland）
Cohera Medical（USA）
Advanced Medical Solutions Group plc（UK）
Ocular Therapeutix, Inc.（USA）
MicroVal（France）

結論與建議

簡介目錄

Product Code: SQMIG15E2730

Global Fibrin Sealants Market size was valued at USD 639.15 Million in 2024 and is poised to grow from USD 689 Million in 2025 to USD 1256.52 Million by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global fibrin sealants market is primarily driven by the increasing volume of surgical procedures, influenced by an aging population prone to chronic illnesses that necessitate surgery, including cardiovascular and orthopedic conditions. As complex surgeries rise, the reliance on effective hemostatic agents like fibrin sealants grows due to their ability to quickly form stable clots and enhance tissue sealing, ultimately reducing blood loss and recovery times. A significant trend within the market is the advancement of biologic and recombinant DNA technologies, yielding safer and more effective sealants with longer shelf lives and lower immunogenic risks. Enhanced manufacturing processes enable the creation of synthetic, pathogen-free products, while innovative formulations improve adhesion and polymerization speed, thereby broadening the clinical use and acceptance of fibrin sealants in surgical settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fibrin Sealants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fibrin Sealants Market Segments Analysis

Global Fibrin Sealants Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Liquid, Patches, Powder and Others. Based on Technology, the market is segmented into Viral Inactivation, Autologous Donation, Recombinant Production and Others. Based on Application, the market is segmented into Orthopedic Surgery, Cardiovascular surgery, General Surgery, Transplant Surgery and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fibrin Sealants Market

The increasing prevalence of surgical interventions across the globe serves as a major catalyst for the expansion of the global fibrin sealants market. A rise in chronic health conditions, such as heart diseases, cancer, and orthopedic issues, boosts the demand for effective hemostatic solutions, like fibrin sealants, during surgical procedures. This heightened need for reliable and efficient surgical tools plays a crucial role in propelling market development, as healthcare providers seek advanced options to improve patient outcomes and enhance the efficiency of operations. Consequently, the growing emphasis on innovative medical solutions further stimulates market dynamics.

Restraints in the Global Fibrin Sealants Market

The growth of the global fibrin sealants market is hindered by regulatory challenges and protracted approval procedures for these products. The requirement for comprehensive clinical trials and adherence to regulatory standards across various regions extends development timelines, which in turn restricts the introduction of new products into the market. This situation may discourage the availability of cutting-edge fibrin sealant solutions, ultimately affecting the overall market dynamics and innovation in the field. As companies navigate these obstacles, the potential for timely access to advanced offerings remains constrained, impacting both manufacturers and consumers seeking effective wound management options.

Market Trends of the Global Fibrin Sealants Market

The Global Fibrin Sealants market is witnessing a significant uptick fueled by the escalating preference for minimally invasive surgical techniques. As healthcare providers aim to enhance patient outcomes, fibrin sealants are increasingly recognized for their capacity to facilitate quicker recovery times, minimize blood loss, and improve overall surgical results. Their versatility in applications, especially within the fields of cardiovascular and orthopedics, underscores their critical role in procedures where precision and rapid recovery are paramount. This growing demand not only highlights a shift in surgical practices but also signals a broader trend towards advanced materials that support effective healing and patient wellbeing.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Fibrin Sealants Market Size by Product Type & CAGR (2026-2033)

Market Overview
Liquid
- Frozen fibrin sealants
- Freeze dried fibrin sealants
Patches
Powder
Others

Global Fibrin Sealants Market Size by Technology & CAGR (2026-2033)

Market Overview
Viral Inactivation
Autologous Donation
Recombinant Production
Others

Global Fibrin Sealants Market Size by Application & CAGR (2026-2033)

Market Overview
Orthopedic Surgery
Cardiovascular surgery
General Surgery
Transplant Surgery
Others

Global Fibrin Sealants Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Others

Global Fibrin Sealants Market Size & CAGR (2026-2033)

North America (Product Type, Technology, Application, End User)
- US
- Canada
Europe (Product Type, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Baxter International (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivostat A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hemarus (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Kasei Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Z-Medica (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Marquee Biosurgical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hualan Biological Engineering (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corza Medical (USA/Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cohera Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Medical Solutions Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ocular Therapeutix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVal (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments